Literature DB >> 17286760

Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.

T Kobayashi1, H Kimura, Y Okada, Y Inoue, T Kobayashi1, M Shinohara, A Morikawa.   

Abstract

Clinical evidence implicates polymorphonuclear leucocytes in the pathogenesis of vasculitis in Kawasaki disease. We examined modulation of expression of adhesion molecules (CD11b and CD62L) on polymorphonuclear leucocytes and how this expression is related to serum cytokine concentrations. In 18 patients with Kawasaki disease and 15 control subjects, adhesion molecule expression was determined by two-colour immunofluorescence staining of blood leucocytes and flow cytometry. Eight cytokines and chemokines were also measured. In patients with Kawasaki disease, mean fluorescence intensity for CD11b before giving intravenous immunoglobulin was significantly higher than in normal subjects (P<0 x 005). After intravenous immunoglobulin, mean fluorescence intensity for CD11b decreased significantly. With coronary artery lesions present, mean CD11b fluorescence intensity was significantly higher than without coronary artery lesions (P=0 x 005 before intravenous immunoglobulin; P=0 x 024 after intravenous immunoglobulin). No differences were seen in CD62L expression on polymorphonuclear leucocytes between patients with Kawasaki disease and normal subjects. CD11b expression on polymorphonuclear leucocytes correlated positively with serum interleukin (IL)-6, IL-10, granulocyte colony-stimulating factor, percentage of neutrophils among white cells and C-reactive protein. Polymorphonuclear leucocytes from patients with Kawasaki disease showed increased CD11b expression, which was associated with increased serum cytokines and appeared to be related to coronary artery lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286760      PMCID: PMC1868857          DOI: 10.1111/j.1365-2249.2007.03326.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Cell adhesion molecules: selectins and integrins.

Authors:  R González-Amaro; F Sánchez-Madrid
Journal:  Crit Rev Immunol       Date:  1999       Impact factor: 2.214

2.  Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.

Authors:  J Furui; M Ishii; H Ikeda; H Muta; K Egami; Y Sugahara; W Himeno; T Akagi; H Kato; T Matsuishi
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

3.  Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Shiro Naoe; Megumi Wakayama; Yuki Yokouchi
Journal:  Pediatr Int       Date:  2005-06       Impact factor: 1.524

4.  Incidence survey of Kawasaki disease in 1997 and 1998 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; I Oki; S Hirata; T Zhang; T Kawasaki
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

5.  Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease.

Authors:  Kazunori Samada; Hiroshi Igarashi; Hirohiko Shiraishi; Kiyohiko Hatake; Mariko Y Momoi
Journal:  Eur J Pediatr       Date:  2002-08-16       Impact factor: 3.183

6.  CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease.

Authors:  T J Brown; S E Crawford; M L Cornwall; F Garcia; S T Shulman; A H Rowley
Journal:  J Infect Dis       Date:  2001-08-22       Impact factor: 5.226

7.  Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease.

Authors:  H Senzaki; S Masutani; J Kobayashi; T Kobayashi; H Nakano; H Nagasaka; N Sasaki; H Asano; S Kyo; Y Yokote
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

8.  Serum levels of neutrophil activation cytokines in Kawasaki disease.

Authors:  H Suzuki; E Noda; M Miyawaki; T Takeuchi; S Uemura; M Koike
Journal:  Pediatr Int       Date:  2001-04       Impact factor: 1.524

9.  Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis.

Authors:  Y Niwa; K Sohmiya
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

Review 10.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

View more
  6 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.

Authors:  Sadeep Shrestha; Howard Wiener; Aditi Shendre; Richard A Kaslow; Jianming Wu; Aaron Olson; Neil E Bowles; Hitendra Patel; Jeffrey C Edberg; Michael A Portman
Journal:  Circ Cardiovasc Genet       Date:  2012-05-07

3.  CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Authors:  Ho-Chang Kuo; Mei-Chyn Chao; Yu-Wen Hsu; Ying-Chi Lin; Ying-Hsien Huang; Hong-Ren Yu; Ming-Feng Hou; Chi-Di Liang; Kuender D Yang; Wei-Chiao Chang; Chih-Lu Wang
Journal:  ScientificWorldJournal       Date:  2012-05-02

4.  Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.

Authors:  Ling-Sai Chang; Kuang-Den Chen; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 5.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

Review 6.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.